Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Dermatology

Standard Medical Treatments for Lipodermatosclerosis

At a Glance

Clinician-prescribed compression after checking arterial blood flow is the foundation of lipodermatosclerosis treatment. It can ease swelling and pain and lower ulcer risk; procedures may treat leaking veins, but long-standing skin hardening and pigmentation may persist.

Treating lipodermatosclerosis (LDS) focuses on one primary goal: reducing the high pressure in your veins (venous hypertension) that is damaging your skin and fat [1]. It is important to set realistic expectations: while compression and procedures can reduce swelling, relieve pain, and lower future ulcer risk, the established woody fibrosis and deep pigmentation of the chronic phase may improve only slowly and often do not completely disappear. While there are several treatment options, the foundation of care is mechanical support and, in some cases, procedures to fix faulty veins.

The Foundation: Compression Therapy

Compression is the most important treatment for LDS [2]. By applying external pressure, these garments help your calf muscles push blood back toward your heart and reduce the leakage of fluid into your tissues.

Practical Compression Checklist:

  • Pressure Targets: Some advanced venous-disease protocols aim for approximately 40 mmHg of pressure [3]. However, this is not a universal standard. Your level must be clinician-prescribed and fitted based on your arterial flow, edema, heart failure status, neuropathy, leg shape, and tolerance. A tolerable lower pressure (such as 20–30 mmHg) is much better than a high-pressure stocking that is so uncomfortable you don’t wear it [4][2].
  • The Safety Check: Before you start any strong compression, your doctor must perform an Ankle-Brachial Index (ABI) or toe pressure test to check your arterial blood flow [5]. If your arteries are narrowed (peripheral artery disease), high-pressure compression can be dangerous because it might cut off the blood supply to your feet [6]. Reduced compression may be used for borderline arterial flow under strict supervision.
  • When to Seek Immediate Advice: Remove your compression and seek prompt medical advice if it causes new numbness, coldness, pale or blue discoloration, weakness, or increasingly severe pain.
  • Managing the Acute Phase: During the “red leg” phase, your leg may be too painful for tight elastic stockings, and compression in a newly red leg should be clinician-directed until infection and DVT have been considered. In these cases, doctors often use multilayer bandages (applied by trained personnel) or adjustable velcro wraps, which can be easier to tolerate until the initial inflammation goes down [7][2]. Clinicians may also prescribe a short course of topical corticosteroid, emollient, and appropriate analgesia after infection has been assessed.

Fixing the Source: Vein Procedures

If an ultrasound shows that specific veins are leaking (refluxing), your care team may recommend a procedure to close or remove them.

  • Endovenous Ablation: This is a minimally invasive procedure where a doctor uses heat (thermal) or medical glue/foam (non-thermal) to close off a malfunctioning superficial vein [8][9].
  • Timing: If you have an active open sore (venous leg ulcer) along with LDS, early treatment of superficial reflux (within two weeks) has been shown to speed up healing, provided you have adequate arterial perfusion and no major contraindications [10]. For skin changes without an ulcer, procedures are considered when current evidence and your symptoms support it [8]. These procedures can reduce venous pressure but do not guarantee ulcer prevention in every patient.
  • Deep Vein Issues: Venous stents are generally for selected significant obstructions, usually in the iliac or pelvic outflow, rather than for ordinary deep-vein reflux [11].

The Role of Medications

There is no “magic pill” for LDS, and medications are generally considered secondary to evidence-supported compression and wound care [1].

  • Pentoxifylline: This drug is sometimes used to improve blood flow and reduce inflammation. While it is an effective adjunct for healing venous ulcers, its effectiveness for the skin thickening of LDS without an ulcer is less clear [2][5]. The most common side effects are nausea and other digestive upsets [12].
  • Stanozolol: This is an older anabolic steroid that was traditionally used off-label because of a proposed—but not established—mechanism to help break down scar tissue [13]. Most patients will never receive it. It is a rarely considered, specialist-only treatment due to limited evidence and potentially serious side effects, including:
    • Lipid Changes: It can significantly lower your “good” (HDL) cholesterol [14].
    • Liver Stress: It can cause temporary or, in rare cases, serious liver injury [15][16].
    • Hormonal Effects: In women, it may cause deepening of the voice or unwanted hair growth; in men, it can cause breast tissue growth or acne [17].

Because of these risks, including pregnancy/lactation and relevant liver or lipid contraindications, stanozolol is extremely limited in use. Laboratory monitoring does not eliminate these risks [14].

Common questions in this guide

What is the main treatment for lipodermatosclerosis?
Compression therapy is the foundation of treatment because it reduces pressure in the leg veins, swelling, pain, and future ulcer risk. It can improve symptoms, but long-standing skin hardening and dark pigmentation may improve slowly or may not disappear completely.
How can I tell whether compression is safe for my leg?
A clinician should check arterial blood flow with an Ankle-Brachial Index or toe pressure test before strong compression is used. Remove the compression and seek prompt medical advice if you develop new numbness, coldness, pale or blue toes, weakness, or worsening pain.
What compression strength should I use for lipodermatosclerosis?
The right pressure depends on your arterial circulation, swelling, heart and nerve health, leg shape, and tolerance. Some advanced protocols use about 40 mmHg, but a lower pressure such as 20 to 30 mmHg may be safer and more practical; consistently wearing a tolerable garment is better than abandoning an uncomfortable one.
Can a vein procedure improve lipodermatosclerosis?
If an ultrasound finds a superficial vein that is allowing blood to flow backward, endovenous ablation can close that vein and reduce venous pressure. When a venous ulcer is present, early treatment may speed healing in suitable patients, but vein procedures do not guarantee that an ulcer will be prevented.
Do medicines help treat lipodermatosclerosis?
Medicines generally supplement rather than replace compression and wound care. Pentoxifylline may help healing of venous ulcers, but its benefit for skin thickening without an ulcer is less certain; stanozolol is rarely considered because its evidence is limited and it can cause liver, cholesterol, and hormone-related problems.
What should happen if my leg becomes suddenly red and painful?
A newly red, painful leg should be assessed by a clinician before tight elastic compression is started because infection and a blood clot in a deep vein may need to be ruled out. Trained staff may use multilayer bandages or adjustable wraps, and a clinician may recommend a short course of skin treatment and pain relief after infection has been assessed.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was my Ankle-Brachial Index (ABI) or Toe-Brachial Index, and is my arterial blood flow sufficient for compression?
  2. 2.Given the pain in my leg, can we start with a lower compression level or adjustable wraps and gradually increase the pressure?
  3. 3.Does my ultrasound show superficial reflux that could be treated with an evidence-based procedure like endovenous ablation?
  4. 4.If we consider medications like pentoxifylline, what side effects should I watch for?
  5. 5.Are there donning aids or a specialized wound clinic you recommend to help me stay consistent with my compression therapy?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Lipodermatosclerosis: from pathophysiology to treatment.

    Alsararatee HH

    British journal of nursing (Mark Allen Publishing) 2025; (34(3)):134-139 doi:10.12968/bjon.2024.0448.

    PMID: 39918931
  2. 2

    Specific management of lipodermatosclerosis (sclerotic hypodermitis) in acute and chronic phase.

    Klejtman T, Lazareth I, Yannoutsos A, Priollet P

    Journal de medecine vasculaire 2022; (47(4)):186-190 doi:10.1016/j.jdmv.2022.10.006.

    PMID: 36344029
  3. 3

    What is the recommended compression pressure for different clinical indications?

    Mosti G, Benigni JP, Caggiati A

    Phlebology 2026; (41(7)):600-610 doi:10.1177/02683555251410002.

    PMID: 41432038
  4. 4

    A reduced multicomponent bandage compression system in the management of venous leg ulcers: a clinical evaluation.

    Tickle J, Robinson H, Stubbings W, et al.

    Journal of wound care 2025; (34(11)):922-931 doi:10.12968/jowc.2025.0457.

    PMID: 41201874
  5. 5

    Venous Ulcers: Diagnosis and Treatment.

    Bonkemeyer Millan S, Gan R, Townsend PE

    American family physician 2019; (100(5)):298-305.

    PMID: 31478635
  6. 6

    Compression therapy after invasive treatment of superficial veins of the lower extremities: Clinical practice guidelines of the American Venous Forum, Society for Vascular Surgery, American College of Phlebology, Society for Vascular Medicine, and International Union of Phlebology.

    Lurie F, Lal BK, Antignani PL, et al.

    Journal of vascular surgery. Venous and lymphatic disorders 2019; (7(1)):17-28 doi:10.1016/j.jvsv.2018.10.002.

    PMID: 30554745
  7. 7

    Compression Therapy Using Bandages Successfully Manages Acute or Subacute Lipodermatosclerosis.

    Suehiro K, Morikage N, Harada T, et al.

    Annals of vascular diseases 2019; (12(1)):77-79 doi:10.3400/avd.cr.18-00135.

    PMID: 30931064
  8. 8

    1% polidocanol endovenous microfoam (VarithenaTM) for the treatment of chronic venous disease: A position statement from the American vein and lymphatic society.

    Meissner MH, Di Iorio M, Davies A

    Phlebology 2026; (41(2)):89-96 doi:10.1177/02683555251353150.

    PMID: 40537050
  9. 9

    A Systematic Review and Meta-Analysis of Randomised Controlled Trials Comparing Thermal Versus Non-Thermal Endovenous Ablation in Superficial Venous Incompetence.

    Shahzad N, Elsherif M, Obaidat I, Brar R

    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2023; (66(5)):687-695 doi:10.1016/j.ejvs.2023.06.002.

    PMID: 37295602
  10. 10

    A Randomized Trial of Early Endovenous Ablation in Venous Ulceration.

    Gohel MS, Heatley F, Liu X, et al.

    The New England journal of medicine 2018; (378(22)):2105-2114 doi:10.1056/NEJMoa1801214.

    PMID: 29688123
  11. 11

    A systematic review of management of superficial venous reflux in the setting of deep venous obstruction.

    Benfor B, Peden EK

    Journal of vascular surgery. Venous and lymphatic disorders 2022; (10(4)):945-954.e2 doi:10.1016/j.jvsv.2021.12.087.

    PMID: 35066218
  12. 12

    Pentoxifylline for intermittent claudication.

    Broderick C, Forster R, Abdel-Hadi M, Salhiyyah K

    The Cochrane database of systematic reviews 2020; (10()):CD005262 doi:10.1002/14651858.CD005262.pub4.

    PMID: 33063850
  13. 13

    Oxandrolone for treatment of lipodermatosclerosis: case report.

    Péret LA, Vidal HM, Gomes GAC, et al.

    Jornal vascular brasileiro 2019; (18()):e20190031 doi:10.1590/1677-5449.190031.

    PMID: 31723343
  14. 14

    Liver enzymes and lipid levels in patients with lipodermatosclerosis and venous ulcers treated with a prototypic anabolic steroid (stanozolol): a prospective, randomized, double-blinded, placebo-controlled trial.

    Carson P, Hong CJ, Otero-Vinas M, et al.

    The international journal of lower extremity wounds 2015; (14(1)):11-8 doi:10.1177/1534734614562276.

    PMID: 25652757
  15. 15

    Stanozolol-induced Liver Injury: A Distinctive Cholestatic Clinical and Biochemical Phenotype at Presentation.

    Nunes V, Schinoni MI, Bessone F, et al.

    Journal of clinical and experimental hepatology 2025; (15(3)):102506 doi:10.1016/j.jceh.2025.102506.

    PMID: 40040852
  16. 16

    Fatal anabolic androgenic steroid overdose in an amateur bodybuilder: a clinical and autopsy report.

    Shaha KK, Nagappan R, Badhe BA

    Forensic science, medicine, and pathology 2024; (20(4)):1420-1424 doi:10.1007/s12024-023-00747-7.

    PMID: 37948000
  17. 17

    MECHANISMS IN ENDOCRINOLOGY: Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions.

    Nieschlag E, Vorona E

    European journal of endocrinology 2015; (173(2)):R47-58 doi:10.1530/EJE-15-0080.

    PMID: 25805894

This page explains lipodermatosclerosis treatments and compression safety for informational purposes only and does not constitute medical advice. A clinician should assess your arterial circulation and prescribe the safest compression and treatment plan for your situation.

Get notified when new evidence is published on Lipodermatosclerosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.